FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Valsartan

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

168 API Suppliers, 49 USDMF, 41 CEP/COS, 28 JDMF, 21 EU WC, 87 KDMF, 20 NDC API, 53 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

46 Drugs in Development

46 Drugs in Development

INTERMEDIATES

29 Intermediate Suppliers

29 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2536 FDF Dossiers, 288 FDA Orange Book, 1690 Europe, 73 Canada, 116 Australia, 130 South Africa, 239 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 5MG BASE;80MG, TABLET;ORAL - 12.5MG;160MG, TABLET;ORAL - 12.5MG;320MG, TABLET;ORAL - 12.5MG;80MG, TABLET;ORAL - 25MG;160MG, TABLET;ORAL - 25MG;320MG, TABLET;ORAL - 160MG, TABLET;ORAL - 320MG, TABLET;ORAL - 40MG, TABLET;ORAL - 80MG, TABLET;ORAL - EQ 10MG BASE;160MG, TABLET;ORAL - EQ 10MG BASE;320MG, TABLET;ORAL - EQ 5MG BASE;160MG, TABLET;ORAL - EQ 5MG BASE;320MG, TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG, TABLET;ORAL - EQ 10MG BASE;25MG;160MG, TABLET;ORAL - EQ 10MG BASE;25MG;320MG, TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG, TABLET;ORAL - EQ 5MG BASE;25MG;160MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 17 SPI Pharma, 1 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 35 BASF, 1 Bioplus Life Sciences, 2 Clariant, 10 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 2 Gloria Interchem, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 1 JJ Chemicals, 26 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 2 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 15 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

82 Fillers, Diluents & Binders, 49 Direct Compression, 48 Coating Systems & Additives, 45 Disintegrants & Superdisintegrants, 38 Granulation, 36 Solubilizers, 30 Controlled & Modified Release, 28 Thickeners and Stabilizers, 24 Topical, 23 Parenteral, 22 Taste Masking, 22 Film Formers & Plasticizers, 20 Chewable & Orodispersible Aids, 19 Lubricants & Glidants, 15 Co-Processed Excipients, 11 Surfactant & Foaming Agents, 11 Emulsifying Agents, 7 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 293 News #PharmaBuzz

GLOBAL SALES INFORMATION

39 US Medicaid Prescriptions, 300 Regulatory FDF Prices, 24 Annual Reports

MARKET PLACE

41 APIs, 10 FDF Dossiers

PATENTS & EXCLUSIVITIES

34 US Patents, 18 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 JP, 24 Others

ANALYTICAL

2 BioAnalytical Methods, 3 Analytical Methods

$ Xls

Filters

TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG

TABLET;ORAL - EQ 10MG BASE;25MG;160MG

TABLET;ORAL - EQ 10MG BASE;25MG;320MG

TABLET;ORAL - EQ 5MG BASE;25MG;160MG

TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG

TABLET;ORAL - EQ 10MG BASE;160MG

TABLET;ORAL - EQ 10MG BASE;320MG

TABLET;ORAL - EQ 5MG BASE;320MG

TABLET;ORAL - EQ 5MG BASE;160MG

TABLET;ORAL - EQ 5MG BASE;80MG

TABLET;ORAL - 12.5MG;160MG

TABLET;ORAL - 12.5MG;320MG

TABLET;ORAL - 12.5MG;80MG

TABLET;ORAL - 25MG;160MG

TABLET;ORAL - 25MG;320MG

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Valsartan

Valsartan

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

168 API Suppliers

49 USDMF

41 CEP/COS

28 JDMF

21 EU WC

87 KDMF

20 NDC API

53 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

46 Drugs in Development

INTERMEDIATES

29 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2536 FDF Dossiers

288 FDA Orange Book

1690 Europe

73 Canada

116 Australia

130 South Africa

239 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 5MG BASE;80MG

TABLET;ORAL - 12.5MG;160MG

TABLET;ORAL - 12.5MG;320MG

TABLET;ORAL - 12.5MG;80MG

TABLET;ORAL - 25MG;160MG

TABLET;ORAL - 25MG;320MG

TABLET;ORAL - 160MG

TABLET;ORAL - 320MG

TABLET;ORAL - 40MG

TABLET;ORAL - 80MG

TABLET;ORAL - EQ 10MG BASE;160MG

TABLET;ORAL - EQ 10MG BASE;320MG

TABLET;ORAL - EQ 5MG BASE;160MG

TABLET;ORAL - EQ 5MG BASE;320MG

TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG

TABLET;ORAL - EQ 10MG BASE;25MG;160MG

TABLET;ORAL - EQ 10MG BASE;25MG;320MG

TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG

TABLET;ORAL - EQ 5MG BASE;25MG;160MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

17 SPI Pharma

1 Pharm-RX Chemical

10 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Kirsch Pharma

1 ACG Worldwide

7 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

35 BASF

1 Bioplus Life Sciences

2 Clariant

10 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

2 Gloria Interchem

1 Huzhou Sunflower Pharmaceutical

5 Ideal Cures

5 Ingredion Pharma Solutions

1 JJ Chemicals

26 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel